Anticipate generic drug launch
Manage your formulary budget
Deep knowledge on
small-molecule drugs and
the 110,000 global patents
Find generic entry opportunities
Drug patents …
… from Kazakhstan to Kalamazoo
Proactively manage your pharmacy inventory
Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing
|Title:||Methods and apparatus for delivery of ocular implants|
|Abstract:||An apparatus and methods for delivering ocular implants or microimplants. The apparatus is ergonomically designed for ease of use, and a simple manual depression of an actuator produces proportional movement of a linkage causing the implant or microimplant to be ejected through a cannula disposed at the desired location in the eye. Small gauge cannulas are provided for self-sealing methods of delivery.|
|Inventor(s):||Weber; David A. (Danville, CA), Kane; Ingrid (Los Altos, CA), Rehal; Mike (Boulder Creek, CA), Lathrop, III; Robert L. (Santa Clara, CA), Aptekarev; Kenny (Santa Cruz, CA), Etter; Jeffrey (Hayward, CA)|
|Assignee:||Allergan, Inc. (Irvine, CA)|
|Filing Date:||Sep 18, 2003|
|Claims:||1. An apparatus for implanting an ocular implant at a location in a patient's eye comprising: a cannula having a lumen extending therethrough configured to receive an ocular implant; and means for retaining an implant received within the cannula lumen to minimize inadvertent release of the implant from the cannula wherein the retention means comprises a frictional stop which extends into the cannula lumen for contacting an implant received therein, wherein the frictional stop comprises an O-ring, at least a portion of which extends into the cannula lumen for contacting an implant received therein, wherein the cannula includes a notch, the notch providing for communication between the cannula lumen and cannula exterior, and wherein the O-ring is positioned around the cannula and where a portion of the O-ring is received in the notch and extends into the cannula lumen. |
2. The apparatus of claim 1 wherein the cannula includes a notch, the notch providing for communication between the cannula lumen and cannula exterior, and wherein the frictional stop comprises tubing positioned around the cannula and where a portion of the tubing is received in the notch and extends into the lumen.
3. The apparatus of claim 1 wherein the frictional stop comprises a spring mechanism.
4. The apparatus of claim 1 wherein the frictional stop is integral to the cannula.
5. The apparatus of claim 1 wherein the retention means comprises a biocompatible adhesive for adhering the implant to the lumen.
6. The apparatus of claim 1 wherein the retention means comprises a frictional coating applied to the cannula lumen.
7. The apparatus of claim 1 wherein the retention means comprises a breakable membrane deployed within the cannula lumen.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.